Related Experiment Video
Updated: Jun 3, 2025
Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration
Published on: February 2, 2024
Demystifying EV heterogeneity: emerging microfluidic technologies for isolation and multiplexed profiling of
Guihua Zhang1, Xiaodan Huang1, Sinong Liu1
1The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, The Key Laboratory of Chemical Biology of Fujian Province, State Key Laboratory of Physical Chemistry of Solid Surfaces, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China. zhuzhi@xmu.edu.cn.
Microfluidic technology offers efficient isolation and multiplex detection of extracellular vesicles (EVs), overcoming limitations of traditional methods. This advancement aids in understanding EV heterogeneity for improved disease diagnostics and personalized therapies.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- Extracellular vesicles (EVs) are crucial biomarkers for disease detection due to their complex molecular cargo.
- Traditional EV isolation methods are inefficient, labor-intensive, and hinder clinical applications.
- Single biomarker analysis lacks the accuracy needed for modern diagnostics.
Purpose of the Study:
- To review microfluidic-based techniques for extracellular vesicle (EV) isolation and multiplex detection.
- To address the challenges in isolating high-purity EVs for clinical use.
- To explore how microfluidics can unravel EV heterogeneity for improved diagnostics.
Main Methods:
- Discussion of microfluidic platforms for EV isolation.
- Analysis of integrated systems for multiplex EV biomarker detection.
- Review of techniques for enhancing EV purity and characterization.
Main Results:
- Microfluidic approaches enable efficient and rapid isolation of EVs.
- Multiplex detection platforms allow simultaneous analysis of multiple EV biomarkers.
- These techniques promise to overcome limitations of conventional EV analysis.
Conclusions:
- Microfluidic-based EV multiplexing platforms are a promising solution for clinical diagnostics.
- These advancements can facilitate the development of sensitive liquid biopsies.
- Demystifying EV heterogeneity through microfluidics offers opportunities for personalized therapy.
